Frank Santoro, MD
Chief Medical Officer
Frank Santoro, M.D. joined Novella Clinical (formerly PharmaLinkFHI) as Chief Medical Officer in May 2008 with more than 20 years clinical research experience. Prior to joining Novella Clinical, Dr. Santoro served as Vice President, Clinical Development and Medical Affairs for Protherics, a UK-based biopharmaceutical company specializing in oncology and critical care products. In that capacity, he provided medical oversight and clinical study management for the companys clinical development programs.
Prior to Protherics, Dr. Santoro worked in the Contract Research Organization (CRO) industry for more than seventeen years in positions of increasing responsibility, including ClinTrials Research, Innovex, Kendle International and Covance, where he built medical and clinical research capabilities to service clients development programs. He has extensive experience managing global operations having directed global project management, clinical monitoring, pharmacovigilance, regulatory and biometric services.
During his career, Dr. Santoro has served as project physician for more than 100 domestic and international studies, and directed project team activities for numerous multi-therapeutic Phase I-IV research programs.